ZAI LAB's stock price soared 5.02% during the intraday trading session on Tuesday, marking a significant upward movement for the innovative drug concept stock.
The surge in Hong Kong appears to follow strong performance in U.S. markets, where Zai Lab's American Depositary Receipts (ADRs) surged 9.7% in Monday's trading session. This positive momentum from the U.S. market likely carried over to the Hong Kong listing at the market open.
The broader Hong Kong market also opened higher, with the Hang Seng Index gaining 0.34% and the Hang Seng Tech Index rising 0.45% at the start of trading.